Michael F MacLean sold $364K of Avidity Biosciences (RNA)

Executed Dec 18 2024, disclosed Dec 19 2024, 1 day later.

Value, as filed

$364K

11,151 sh × $32.66

Executed

Dec 18 2024

the trade date, as filed

Disclosed

Dec 19 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MM Michael F MacLean Chief Financial Officer profile →

Michael F MacLean (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $329K of RNA (4,542 sh across 2 lots, as filed), executed Jan 21.

The name

RNA RNA RNA · 61 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael F MacLean in RNA

RNASALE Avidity Biosciences, Inc. $329K
4,542 sh across 2 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $143K
1,974 sh × $72.23
Exec Jan 7
Filed Jan 9 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $1.3M
30,914 sh × $42.73
Exec Aug 6 2025
Filed Aug 15 2025 · 5:30 PM ET † RNASALE Avidity Biosciences, Inc. $246K
7,935 sh × $31.06
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $4.8M
106,319 sh across 3 lots
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $506K
11,510 sh × $44.00
Exec Sep 23 2024
Filed Sep 23 2024 · 5:30 PM ET